Cathepsin L splice variants in human breast cell lines

Biological Chemistry

Volumn 387, Issue 5, 2006, Pages 629-634

  Caserman, Simon ^a   Kenig, Saša ^a   Sloane, Bonnie F ^b   Lan, Tamara T ^a  

^a NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cathepsin L; Invasiveness; ras oncogene; Splice variant

Indexed keywords

CATHEPSIN L; ENZYME VARIANT; MESSENGER RNA;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER GROWTH; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RNA TRANSLATION; TRANSCRIPTION REGULATION;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CATHEPSINS; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

EID: 33746055274     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.080     Document Type: Article

References (27)

1. Abudula, A., Rommerskirch, W., Weber, E., Gunther, D., and Wiederanders, B. (2001). Splice variants of human cathepsin L mRNA show different expression rates. Biol. Chem. 382, 1583-1591.
2. Afonso, S., Romagnano, L., and Babiarz, B. (1997). The expression and function of cystatin C and cathepsin B and cathepsin L during mouse embryo implantation and placentation. Development 124, 3415-3425.
3. Arora, S. and Chauhan, S.S. (2002). Identification and characterization of a novel human cathepsin L splice variant. Gene 293, 123-131.
4. Bervar, A., Zajc, I., Sever, N., Katunuma, N., Sloane, B.F., and Lah, T.T. (2003). Invasiveness of transformed human breast epithelial cell lines is related to cathepsin B and inhibited by cysteine proteinase inhibitors. Biol. Chem. 384, 447-455.
5. Chauhan, S.S., Goldstein, L.J., and Gottesman, M.M. (1991). Expression of cathepsin L in human tumors. Cancer Res 51, 1478-1481.
6. Chauhan, S.S., Popescu, N.C., Ray, D., Fleischmann, R., Gottesman, M.M., and Troen, B.R. (1993). Cloning, genomic organization, and chromosomal localization of human cathepsin L. J. Biol. Chem. 268, 1039-1045.
7. Collette, J., Ulku, A.S., Der, C.J., Jones, A., and Erickson, A.H. (2004). Enhanced cathepsin L expression is mediated by different Ras effector pathways in fibroblasts and epithelial cells. Int. J. Cancer 112, 190-199.
8. Dawson, P.J., Wolman, S.R., Tait, L., Heppner, G.H., and Miller, F.R. (1996). MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am. J. Pathol. 148, 313-319.
9. Gal, S., Willingham, M.C., and Gottesman, M.M. (1985). Processing and lysosomal localization of a glycoprotein whose secretion is transformation stimulated. J. Cell Biol. 100, 535-544.
10. Jean, D., Guillaume, N., and Frade, R. (2002). Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity. Biochem. J. 361, 173-184.
11. Joseph, L.J., Chang, L.C., Stamenkovich, D., and Sukhatme, V.P. (1988). Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts. J. Clin. Invest. 81, 1621-1629.
12. Kirschke, H., Clausen, T., Gohring, B., Gunther, D., Heucke, E., Laube, F., Lowe, E., Neef, H., Papesch, H., Peinze, S., et al. (1997). Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney. J. Cancer Res. Clin. Oncol. 123, 402-406.
13. Lah, T.T. and Kos, J. (1998). Cysteine proteinases in cancer progression and their clinical relevance for prognosis. Biol. Chem. 379, 125-130.
14. Lah, T.T., Kokalj-Kunovar, M., Drobnič-Košorok, M., Babnik, J., Golouh, R., Vrhovec, I., and Turk, V. (1992a). Cystatins and cathepsins in breast carcinoma. Biol. Chem. Hoppe-Seyler 373, 595-604.
15. Lah, T.T., Kokalj-Kunovar, M., Štrukelj, B., Pungerčar, J., Barlič-Maganja, D., Drobnič-Košorok, M., Kastelic, L., Babnik, L., Golouh, R., and Turk, V. (1992b). Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int. J. Cancer 50, 36-44.
16. Meijers, M.H., Koopdonk-Kool, J., Meacock, S.C., Van Noorden, C.J., Bunning, R.A., and Billingham, M.E. (1993). Cysteine proteinase activity in the development of arthritis in an adjuvant model of the rat. Agents Actions 39, C219-C221.
17. Miller, F.R., Soule, H.D., Tait, L., Pauley, R.J., Wolman, S.R., Dawson, P.J., and Heppner, G.H. (1993). Xenograft model of progressive human proliferative breast disease. J. Natl. Cancer Inst. 85, 1725-1732.
18. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J.A., Ploegh, H., Peters, C., and Rudensky, A.Y. (1998). Cathepsin L: critical role in li degradation and CD4 T cell selection in the thymus. Science 280, 450-453.
19. Potts, W., Bowyer, J., Jones, H., Tucker, D., Freemont, A.J., Millest, A., Martin, C., Vernon, W., Neerunjun, D., Slynn, G., et al. (2004). Cathepsin L-deficient mice exhibit abnormal skin and bone development and show increased resistance to osteoporosis following ovariectomy. Int. J. Exp. Pathol. 85, 85-96.
20. Price, J.E., Polyzos, A., Zhang, R.D., and Daniels, L.M. (1990). Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50, 717-721.
21. Rescheleit, D.K., Rommerskirch, W.J., and Wiederanders, B. (1996). Sequence analysis and distribution of two new human cathepsin L splice variants. FEBS Lett. 394, 345-348.
22. Robker, R.L., Russell, D.L., Espey, L.L., Lydon, J.P., O'Malley, B.W., and Richards, J.S. (2000). Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc. Natl. Acad. Sci. USA 97, 4689-4694.
23. Santner, S.J., Dawson, P.J., Tait, L., Soule, H.D., Eliason, J., Mohamed, A.N., Wolman, S.R., Heppner, G.H., and Miller, FR. (2001). Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res. Treat. 65, 101-110.
24. Seth, P., Mahajan, V.S., and Chauhan, S.S. (2003). Transcription of human cathepsin L mRNA species hCATL B from a novel alternative promoter in the first intron of its gene. Gene 321, 83-91.
25. Thompson, E.W., Paik, S., Brunner, N., Sommers, C.L., Zugmaier, G., Clarke, R., Shima, T.B., Torri, J., Donahue, S., Lippman, M.E., et al. (1992). Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J. Cell Physiol. 150, 534-544.
26. Trinkaus, M., Vranič, A., Dolenc, V.V., and Lah, T.T. (2005). Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas. Int. J. Biol. Markers 20, 50-59.
27. Zajc, I., Sever, N., Bervar, A., and Lah, T.T. (2002). Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines. Cancer Lett. 187, 185-190.